The SNP rs6500843 in 16p13.3 is associated with survival specifically among chemotherapy-treated breast cancer patients.
Fagerholm, Rainer
The SNP rs6500843 in 16p13.3 is associated with survival specifically among chemotherapy-treated breast cancer patients. [electronic resource] - Oncotarget Apr 2015 - 7390-407 p. digital
Publication Type: Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
1949-2553
10.18632/oncotarget.3506 doi
Adult
Aged
Aged, 80 and over
Anthracyclines--administration & dosage
Antineoplastic Combined Chemotherapy Protocols--therapeutic use
Breast Neoplasms--drug therapy
Chemotherapy, Adjuvant
Deoxycytidine--administration & dosage
Female
Genome-Wide Association Study
Humans
Middle Aged
Multivariate Analysis
Polymorphism, Single Nucleotide
Prognosis
Quantitative Trait Loci
Survival Analysis
Taxoids--administration & dosage
Young Adult
Gemcitabine
The SNP rs6500843 in 16p13.3 is associated with survival specifically among chemotherapy-treated breast cancer patients. [electronic resource] - Oncotarget Apr 2015 - 7390-407 p. digital
Publication Type: Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
1949-2553
10.18632/oncotarget.3506 doi
Adult
Aged
Aged, 80 and over
Anthracyclines--administration & dosage
Antineoplastic Combined Chemotherapy Protocols--therapeutic use
Breast Neoplasms--drug therapy
Chemotherapy, Adjuvant
Deoxycytidine--administration & dosage
Female
Genome-Wide Association Study
Humans
Middle Aged
Multivariate Analysis
Polymorphism, Single Nucleotide
Prognosis
Quantitative Trait Loci
Survival Analysis
Taxoids--administration & dosage
Young Adult
Gemcitabine